-transparent.png){kind=logo}
1. The effect of the divalent cation Zn2+ on inhibitory glycine receptor (GlyR) currents was investigated in rat embryonic spinal cord neurons and Xenopus oocytes expressing recombinant GlyRs. 2. In cultured spinal neurons, Zn2+ potentiated glycine-induced whole-cell currents about 3-fold when applied extracellularly at concentrations of 0.5-10 microM. In contrast, higher concentrations (> 100 microM) of Zn2+ decreased the glycine response. 3. A similar biphasic modulation of glycine-induced currents by Zn2+ was also found with recombinant homo- and hetero-oligomeric GlyRs generated in Xenopus oocytes. Dose-response analysis showed that both the potentiating and inhibitory effects of Zn2+ result from changes in apparent agonist affinity. 4. Analysis of chimeric constructs of the GlyR alpha 1- and beta-subunits revealed that the positive and negative modulatory effects of Zn2+ are mediated by different regions of the alpha 1-subunit. 5. Our data indicate the existence of distinct high- and low-affinity Zn2+ binding sites on the ligand-binding alpha-subunits of the GlyR. These sites may be implicated in the regulation of synaptic efficacy within glycinergic pathways.
B Laube, and
J Kuhse, and
N Rundström, and
J Kirsch, and
V Schmieden, and
H Betz
July 2011,
Neuroscience,
B Laube, and
J Kuhse, and
N Rundström, and
J Kirsch, and
V Schmieden, and
H Betz
August 2008,
Life sciences,
B Laube, and
J Kuhse, and
N Rundström, and
J Kirsch, and
V Schmieden, and
H Betz
September 2016,
Molecular pharmacology,
B Laube, and
J Kuhse, and
N Rundström, and
J Kirsch, and
V Schmieden, and
H Betz
August 2016,
ACS chemical neuroscience,
B Laube, and
J Kuhse, and
N Rundström, and
J Kirsch, and
V Schmieden, and
H Betz
March 1999,
Proceedings of the National Academy of Sciences of the United States of America,
B Laube, and
J Kuhse, and
N Rundström, and
J Kirsch, and
V Schmieden, and
H Betz
June 1996,
British journal of pharmacology,
B Laube, and
J Kuhse, and
N Rundström, and
J Kirsch, and
V Schmieden, and
H Betz
April 1996,
Cellular and molecular neurobiology,
B Laube, and
J Kuhse, and
N Rundström, and
J Kirsch, and
V Schmieden, and
H Betz
January 2006,
Neuroscience,
B Laube, and
J Kuhse, and
N Rundström, and
J Kirsch, and
V Schmieden, and
H Betz
June 2019,
European journal of pharmacology,
B Laube, and
J Kuhse, and
N Rundström, and
J Kirsch, and
V Schmieden, and
H Betz
January 1996,
Neuropharmacology,
